Profile
Currently, Satoshi Konagai is Director at Cleave Therapeutics, Inc. since 2021, Director at Solu Therapeutics, Inc., and Investment Lead at Astellas Venture Management LLC since 2024.
Formerly, Mr. Konagai was Senior Manager at Astellas Pharma, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Kyoto University conferred in 2002 and 2004, respectively, and an MBA from the University of Massachusetts conferred in 2022.
Satoshi Konagai active positions
| Companies | Position | Start |
|---|---|---|
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Private Equity Investor | 01/10/2020 |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Director/Board Member | 01/12/2021 |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Director/Board Member | - |
Former positions of Satoshi Konagai
| Companies | Position | End |
|---|---|---|
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31/10/2020 |
Training of Satoshi Konagai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management invests in companies located across the globe. The firm focuses on companies operating in the fields of biotechnology, including drug discovery and development. It provides financing for early stage capital requirements. | Finance |
Kyoto University
Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
- Stock Market
- Insiders
- Satoshi Konagai
















